{
    "Trade/Device Name(s)": [
        "BD Vacutainer\u00ae Rapid Serum Tube Plus Blood Collection Tube"
    ],
    "Submitter Information": "BD Diagnostics, Preanalytical Systems",
    "510(k) Number": "K091292",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JKA"
    ],
    "Summary Letter Date": "August 25, 2009",
    "Summary Letter Received Date": "July 22, 2009",
    "Submission Date": "July 21, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.1675"
    ],
    "Regulation Name(s)": [
        "Blood specimen collection devices"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "serology",
        "immunology"
    ],
    "Analyte(s)": [
        "anti-CMV IgG",
        "anti-CMV IgM",
        "CRP",
        "C3",
        "C4",
        "IgG",
        "IgM",
        "Rf",
        "LDL",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Venous blood",
        "Serum"
    ],
    "Specimen Container(s)": [
        "BD Vacutainer\u00ae Rapid Serum Tube Plus Blood Collection Tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Evacuated blood collection tube",
        "Rapid clotting additive"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Specimen collection device",
        "Tube",
        "Container"
    ],
    "Document Summary": "FDA 510(k) summary for BD Vacutainer Rapid Serum Tube Plus Blood Collection Tube for collection, separation, and processing of venous blood specimens for serum chemistry determinations.",
    "Indications for Use Summary": "Single use tube for collecting, separating, transporting and processing venous blood specimens to obtain serum for chemistry determinations for in vitro diagnostic use; not recommended for patients on heparin therapy, direct thrombin inhibitor therapy, or with Factor I deficiency.",
    "fda_folder": "Clinical Chemistry"
}